Search

Your search keyword '"Shchepkin DV"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Shchepkin DV" Remove constraint Author: "Shchepkin DV"
46 results on '"Shchepkin DV"'

Search Results

1. The D75N and P161S Mutations in the C0-C2 Fragment of cMyBP-C Associated with Hypertrophic Cardiomyopathy Disturb the Thin Filament Activation, Nucleotide Exchange in Myosin, and Actin-Myosin Interaction.

2. A trait-based ecological perspective on the soil microbial antibiotic-related genetic machinery.

3. Functional and Structural Properties of Cytoplasmic Tropomyosin Isoforms Tpm1.8 and Tpm1.9.

4. Myopathy-causing mutation R91P in the TPM3 gene drastically impairs structural and functional properties of slow skeletal muscle tropomyosin γβ-heterodimer.

6. Optimization, characterization, and cytotoxicity studies of novel anti-tubercular agent-loaded liposomal vesicles.

7. N-Terminal Fragment of Cardiac Myosin Binding Protein-C Increases the Duration of Actin-Myosin Interaction.

8. N-Terminal Fragment of Cardiac Myosin Binding Protein C Modulates Cooperative Mechanisms of Thin Filament Activation in Atria and Ventricles.

9. Novel Mutation Glu98Lys in Cardiac Tropomyosin Alters Its Structure and Impairs Myocardial Relaxation.

10. Structural and Functional Properties of Kappa Tropomyosin.

11. Pseudo-phosphorylation of essential light chains affects the functioning of skeletal muscle myosin.

12. De Novo Asp219Val Mutation in Cardiac Tropomyosin Associated with Hypertrophic Cardiomyopathy.

13. Impact of Troponin in Cardiomyopathy Development Caused by Mutations in Tropomyosin.

14. Properties of Cardiac Myosin with Cardiomyopathic Mutations in Essential Light Chains.

15. The effects of the tropomyosin cardiomyopathy mutations on the calcium regulation of actin-myosin interaction in the atrium and ventricle differ.

16. Acidosis modifies effects of phosphorylated tropomyosin on the actin-myosin interaction in the myocardium.

17. Effects of myopathy-causing mutations R91P and R245G in the TPM3 gene on structural and functional properties of slow skeletal muscle tropomyosin.

18. Impact of A134 and E218 Amino Acid Residues of Tropomyosin on Its Flexibility and Function.

19. Mechanisms of disturbance of the contractile function of slow skeletal muscles induced by myopathic mutations in the tropomyosin TPM3 gene.

20. Myosin from the ventricle is more sensitive to omecamtiv mecarbil than myosin from the atrium.

21. Comparison of Functional Characteristics of Myosin in Fast and Slow Skeletal Muscles.

22. Unique functional properties of slow skeletal muscle tropomyosin.

23. Functional outcomes of structural peculiarities of striated muscle tropomyosin.

24. Cardiomyopathy-associated mutations in tropomyosin differently affect actin-myosin interaction at single-molecule and ensemble levels.

25. Effect of Interchain Disulfide Crosslinking in the Tropomyosin Molecule on Actin-Myosin Interaction in the Atrial Myocardium.

26. The effects of cardiomyopathy-associated mutations in the head-to-tail overlap junction of α-tropomyosin on its properties and interaction with actin.

27. Myopathic mutations in the β-chain of tropomyosin differently affect the structural and functional properties of ββ- and αβ-dimers.

28. Structural and functional properties of αβ-heterodimers of tropomyosin with myopathic mutations Q147P and K49del in the β-chain.

29. Hydrogen Peroxide Treatment of Muscle Fibres Inhibits the Formation of Myosin Cross-Bridges.

30. The Effect of Experimental Hyperthyroidism on Characteristics of Actin-Myosin Interaction in Fast and Slow Skeletal Muscles.

31. Functional role of the core gap in the middle part of tropomyosin.

32. The isoforms of α-actin and myosin affect the Ca 2+ regulation of the actin-myosin interaction in the heart.

33. Cooperativity of myosin interaction with thin filaments is enhanced by stabilizing substitutions in tropomyosin.

34. Structural and Functional Effects of Cardiomyopathy-Causing Mutations in the Troponin T-Binding Region of Cardiac Tropomyosin.

35. The interchain disulfide cross-linking of tropomyosin alters its regulatory properties and interaction with actin filament.

36. Effect of Cardiac Myosin-Binding Protein C on Tropomyosin Regulation of Actin-Myosin Interaction Using In Vitro Motility Assay.

37. Effect of Cardiomyopathic Mutations in Tropomyosin on Calcium Regulation of the Actin-Myosin Interaction in Skeletal Muscle.

38. Investigations of Molecular Mechanisms of Actin-Myosin Interactions in Cardiac Muscle.

39. Stabilizing the central part of tropomyosin increases the bending stiffness of the thin filament.

40. Structural and functional effects of two stabilizing substitutions, D137L and G126R, in the middle part of α-tropomyosin molecule.

41. Stabilization of the Central Part of Tropomyosin Molecule Alters the Ca2+-sensitivity of Actin-Myosin Interaction.

42. Study of regulatory effect of tropomyosin on actin-myosin interaction in skeletal muscle by in vitro motility assay.

43. Study of reciprocal effects of cardiac myosin and tropomyosin isoforms on actin-myosin interaction with in vitro motility assay.

44. Effects of cardiac myosin binding protein-C on the regulation of interaction of cardiac myosin with thin filament in an in vitro motility assay.

45. [Assessment of the mechanical activity of cardiac isomyosins V1 and V3 by an in vitro motility assay with regulated thin filaments].

46. Study of the interaction between rabbit cardiac contractile and regulatory proteins. An in vitro motility assay.

Catalog

Books, media, physical & digital resources